Board/Management Information • Feb 12, 2019
Board/Management Information
Open in ViewerOpens in native device viewer
• Appointments of Dr. Mondher Mahjoubi, Chief Executive Officer, and Dr. Yannis Morel, EVP Business Development and Portfolio Strategy, renewed to the Executive Board for three years
Marseille, France, February 12, 2019, 7:00 AM CET
Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 – IPH) today announces that the Supervisory Board of Innate Pharma has strengthened the Company's leadership and corporate governance with the appointment of Laure-Hélène Mercier, Chief Financial Officer, as a member of the Executive Board for a period of three years.
Laure-Hélène Mercier, MSc, M MCLaure
Information about Innate Pharma shares:
| ISIN code | FR0010331421 |
|---|---|
| Ticker code | IPH |
| LEI | 9695002Y8420ZB8HJE29 |
This press release contains certain forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. For a discussion of risks and uncertainties which could cause the company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Document de Reference prospectus filed with the AMF, which is available on the AMF website www.amf-france.org or on Innate Pharma's website.
This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
For additional information, please contact:
| Investors | International Media |
|---|---|
| Innate Pharma | Consilium Strategic Communications |
| Dr. Markus Metzger / Danielle Spangler / Jérôme Marino |
Mary-Jane Elliott / Jessica Hodgson |
| Tel.: +44 (0)20 3709 5700 | |
| Tel.: +33 (0)4 30 30 30 30 | [email protected] |
| [email protected] |
Solène Moulin Tel.: +33 (0)9 81 87 46 72 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.